• 대한세포병리학회지
• /
• 제11권1호
• /
• pp.31-34
• /
• 2000

Pulmonary hamartoma is an uncommon benign tumor consisting of a mixture of loose fibromyxoid tissue, cartilage, fat, and cleft-like spaces lined by cuboidal or ciliated epithelium. Cytologically, the presence of a mesenchymal component is essential for the diagnosis of pulmonary hamartoma. We report the fine needle aspiration cytologic findings of two cases of pulmonary hamartoma. Case 1 was a 71-year-old woman with a mass, measuring $1.8{\times}1.5cm$ in the upper lobe of the right lung. Case 2 was a 51-year-old woman with a mass, measuring $2.3{\times}2.0cm$ in the lower lobe of the right lung. Fine needle aspiration cytology of both pulmonary masses revealed several sheets of loose fibromyxoid tissue fragments with focal cartilaginous differentiation and a few clusters of bland cuboidal epithelial cells on the bloody background. The diagnosis was histologically confirmed by needle biopsy.

• 대한세포병리학회지
• /
• 제8권1호
• /
• pp.69-75
• /
• 1997

Well differentiated fetal adenocarcinoma of the lung Is a subtype of pulmonary blastoma. In this report, CT-guided fine needle aspiration smears were performed at the right upper lobe of the lung in a 45 year-old male patient who had the smoking history of one pack per day for 25 years. The smears disclosed round, papillary, and tubular patterns of cell clusters. The individual cells had relatively uniform, small to medium sized nuclei without nucleoli, and showed vesicular or eosinophilic cytoplasm with Indistinct cell border. The morules were seen in the central area of papillary clusters. They were composed of two cell types, outer single layered cuboidal cellular lining and central three-dimensional cluster of cells simulating fetal lung. These cytologic features need to be differentiated from usual pulmonary adenocarcinoma, carcinoid, and pulmonary blastoma. On histologic findings, the tumor arised in the bronchial epithelium. And the tumor cells had abundant intracytoplasmic glycogen with neuroendocrine feature on histochemical study. In addition, the multiplicity of this tumor is the unique point comparable to the previous reports.

• Journal of Chest Surgery
• /
• 제37권8호
• /
• pp.711-714
• /
• 2004

폐동맥 내로 파열되어 응급수술이 필요했던 전종격동의 성숙 낭포성 기형종을 경험하였기에 보고하는 바이다. 39세 여자 환자가 대량객혈을 주소로 내원하여 기관지 동맥 색전술을 시행 받았다. 그러나 기관지 동맥 색전술 시행 10일 후 환자는 갑작스런 대량객혈과 함께 의식저하가 생겨 응급 개흉술을 시행하였다. 수술은 좌측 전폐절제술과 전종격동에 있는 종양절제술을 시행하였으며 조직학적 검사 결과 종양은 성숙 상피세포와 피지선, 성숙 지방조직, 연골, 골조직 등으로 구성된 낭포성 구조물로 관찰되었고, 좌 폐동맥으로 침습된 종양의 일부가 파열되어 폐내출혈을 보이고 있었다.

• Journal of Chest Surgery
• /
• 제14권3호
• /
• pp.210-214
• /
• 1981

The bronchogenic cysts result from an abnormal budding or branching of the tracheo-bronchial tree from the primitive foregut. Bronchogenic cysts may be pulmonary or mediastinal. The most common location for a mediastinal bronchogenic cyst is in relation to the carina. They are usually solitary. They usually are thin walled and contain fluid that is most often clear. The cyst is lined by ciliated columnar epithelium. The bronchogenic cyst i~ usually asymptomatic. They can cause pressure symptoms. When they become infected, symptoms do occur. We report 3 cases of bronchogenic cysts experienced at the Department of Thoracic and Cardiovascular Surgery, Kyungpook National University Hospital. Case I, a man of 20 year-old, had a cyst at the site between aortic arch and left pulmonary artery. He complained cough and dyspnea. The cyst wasn`t communicated with tracheobronchial tree. Case II was 55-year-old male who had had hemoptysis. A huge cyst was located within the lower lobe of left lung and removed by pulmonary lobectomy. There were not any symptoms in Case III that was 6-year old girl. That cyst was located just next to the right main bronchus.

• 대한세포병리학회지
• /
• 제18권1호
• /
• pp.36-45
• /
• 2007

Objective : To identify key cytologic features for diagnosis of adenocarcinoma and morphologic differentiation from reactive/reparative respiratory epithelium. Study Design : The cytomorphologic features of 145 pulmonary cytology specimens (sputum and bronchial washing), which included 117 histologically proven adenocarcinomas and 28 non-neoplastic lesions, cytologically diagnosed as atypia and suspicious for malignancy (adenocarcinoma) were reviewed retrospectively. We analyzed 11 morphologic criteria in pulmonary cytologic specimens. Results: Over 110 of 117 cases of adenocarcinomas revealed nuclear membrane irregularities, non-cohesive cells, single atypical cells, moderate to markedly enlarged nuclei and an increased nuclear/cytoplasmic (N/C) ratio. Chromatin clearing, chromatin heterogeneity and hyperchromasia were seen in 102, 99 and 97 cases, respectively. All 28 cases involving non-neoplastic lesions revealed hyperplastic reactive pneumocytes, hyperplastic reactive bronchial epithelium, or degenerating macrophages. The non-neoplastic lesions revealed a small number of atypical cell clusters and paucity or absence of atypical single cells. Conclusion : The most important morphologic features for diagnosis of adenocarcinoma are nuclear membrane irregularities, non-cohesive cells, single atypical cell, moderate to markedly enlarged nuclei and increased N/C ratio. Chromatin clearing, chromatin heterogeneity and hyperchromasia were also helpful features, while pleomorphism and prominent nucleoli were less valuable.

• Biomolecules & Therapeutics
• /
• 제31권5호
• /
• pp.484-495
• /
• 2023

Idiopathic pulmonary fibrosis (IPF) can be defined as a progressive chronic pulmonary disease showing scarring in the lung parenchyma, thereby resulting in increase in mortality and decrease in the quality of life. The pathophysiologic mechanism of fibrosis in IPF is still unclear. Repetitive microinjuries to alveolar epithelium with genetical predisposition and an abnormal restorative reaction accompanied by excessive deposition of collagens are involved in the pathogenesis. Although the two FDA-approved drugs, pirfenidone and nintedanib, are under use for retarding the decline in lung function of patients suffered from IPF, they are not able to improve the survival rate or quality of life. Therefore, a novel therapeutic agent acting on the major steps of the pathogenesis of disease and/or, at least, managing the clinical symptoms of IPF should be developed for the effective regulation of this incurable disease. In the present review, we tried to find a potential of managing the clinical symptoms of IPF by natural products derived from medicinal plants used for controlling the pulmonary inflammatory diseases in traditional Asian medicine. A multitude of natural products have been reported to exert an antifibrotic effect in vitro and in vivo through acting on the epithelial-mesenchymal transition pathway, transforming growth factor (TGF)- β-induced intracellular signaling, and the deposition of extracellular matrix. However, clinical antifibrotic efficacy of these natural products on IPF have not been elucidated yet. Thus, those effects should be proven by further examinations including the randomized clinical trials, in order to develop the ideal and optimal candidate for the therapeutics of IPF.

• Journal of Pharmaceutical Investigation
• /
• 제40권4호
• /
• pp.231-236
• /
• 2010

This study was to fabricate the porous poly(lactide-co-glycolide) (PLGA) microparticles with anthocyanin (as a model antioxidant) for pulmonary drug delivery. The highly porous PLGA microparticles were prepared by the waterin-oil-in-water ($W_1/O/W_2$) multi-emulsion method, followed by the decomposition of ammonium bicarbonate (AB) in $W_1$ phase to the base of ammonia, carbon dioxide and water vapor at $50^{\circ}C$, making a porous structure in PLGA microparticles. Herein, hyaluronate (HA), a viscous polysaccharide, was incorporated in the porous microparticles for sustained anthocyanin release. In in vitro release studies, the anthocyanin release from the porous microparticles with HA continued up to 24 hours, while the porous microparticles without HA released 80 wt.% of encapsulated anthocyanin within 2 hours. In addition, these microparticle are expected to be effectively deposited at a lung epithelium due to its high porosity (low density) and avoid alveolar macrophage's uptake in the lung due to its large particle size. We believe that this system has a great pharmaceutical potential as a long acting antioxidant for relieving the oxidative stress in chronic obstructive pulmonary disease (COPD).

• Tuberculosis and Respiratory Diseases
• /
• 제58권1호
• /
• pp.31-42
• /
• 2005

배 경 : peroxiredoxins는 거의 모든 생명체에 공통적으로 보존되어 있으며, 최근에 발견된, 특이한 peroxidases로 인체에서 6가지 동위효소가 알려져 있으며, 산화스트레스에 대한 방어역할을 담당하고, $H_2O_2$신호전달 과정에서 중요한 조절 역할을 한다. peroxiredoxin은 $H_2O_2$ 처리 과정 중에서 자신이 산화되어 불활성화 되는데, 산화된 후 다시 재생되는 것으로 보고되나 그 생리적은 의미는 분명하지 않다. 이에 저자들을 폐상 피세포주, 대식세포주, 폐포모세혈관 내피세포주 및 기타 섬유모세포주 들에서 $H_2O_2$ 에 의한 Prx의 산화과정과 재생을 알아보고자 하였다. 방 법 : 수술 환자에서 적출한 정상 폐조직과, 세포주로는 평상시 산화 스트레스에 노출이 많을 것으로 예상되는 세포들로써, 폐포상피세포의 I 형 및 II 형 세포에서 기원한 A549, WI 26, Raw 264.7, Rat2,및 폐포 모세혈관 내피세포주 등을 이용하여 이를 $50{\mu}M$. $100{\mu}M$, $500{\mu}M$ 의 $H_2O_2$로 산화시켜 불활성화 한 후, 추적관찰 하였으며, 시간대 별로(0. 10, 30, 60, 120, 240, 480 분) 수확하여, 이를 1차원 non-reducing SDS-PAGE 및 2차원 전기영동로 분리 후, silver stain 과 Western blot으로 분석 하였다. 결 과 : 1. 실험에 사용된 모든 세포주에서, $H_2O_2$ 농도에 비례하여 peroxiredoxin I, II, III 의 불활성화를 관찰할 수 있었고, 10분에 최고로 불활성화되었다. 2. 산화된 이후, 30분경부터 peroxiredoxin 의 재생이 관찰되기 시작 하였으며, 2시간 이후부터 확연하였다. 3. 다시 재생된 peroxiredoxin은 $H_2O_2$투여로서, 다시 불활성화되어, 재생된 Prx 가 활성을 지닌 단백질임을 알 수 있었다. 4. 재생의 속도는 사용된 세포주마다 차이가 있었으며 (A549 >Raw 264.7 >$Rat_2$ >WI26), 단백질 합성억제제인 cycloheximide ($10{\mu}g/ml$) 존재 하에서도 변함 없이 관찰되었다. 결 론 : 세포 내에는 산화되어 불활성화된 peroxiredoxin을 재생하는 체계가 존재 하며, 이는 활성부위 cysteine을 갖는 다른 단백질에도 공통적으로 적용될 수 있는 분자 스위치일 가능성이 높으며, 산화에 의한 신호전달과정이나, 질병 모델에서 Prx 단백의 재생 체계의 이상과 병인에 관한 추가적인 연구가 필요할 것으로 사료된다.

• 대한한방내과학회지
• /
• 제26권1호
• /
• pp.129-142
• /
• 2005

Objective : Asthma is known as chronic airway inflammatory disease. This inflammation is conducted by various inflammatory cells including eosihophil. Chemotaxis is one way that circulating inflammatory cells invade a specific lesion. This study examines the degree to which Lonicerae Flos inhibits eosinophil chemotaxis at pulmonary epithelium after allergic stimulation. Material and Methods : Water extracts of Lonicerae Flos and pulmonary epithelial cell lines A549(human type II-like epithelial cells) and human eosinophils were used. Cytotoxic effects of Lonicerae Flos via MTS assay were estimated, as well as the effects of Lonicerae Flos on chemokines from prestimulated A549 cells by sandwich ELISA and RT-PCR. Chemotaxis assay was conducted on prestimulated eosinophils treated with Lonicerae Flos. Result : In this study $TNF-{\alpha}$ and IL-4, $IL-l{\beta}$ were seen to induced the accumulation of chemokines mRNA in the pulmonary epithelial cell lines A549 in a dose-dependent manner. Chemokines were inhibited by Liripois Tuber in a dose-dependent manner and especially, IL-8 and ICAM-l were inhibited considerably at $100\;{\mu}g/ml$ concentration of Lonicerae Flos. The eosinophil migration is inhibited in high concentration of Lonicerae Flos in a dose-dependent manner. Conclusion : These findings indicate that the supression of the expression of chemokines can be accomplished by Lonicerae Flos treatment, raising the possibility that Lonicerae Flos might be of therapeutic value in diseases such as asthma.

• 대한기관식도과학회지
• /
• 제15권2호
• /
• pp.30-35
• /
• 2009

Lung cancer could be developed through a series of morphological changes from dysplasia to carcinoma in situ and then invasive cancer. However, precancerous lesions are generally a few cell layers thick and are detected only by chance. Autofluorescence bronchoscopy(AFB) is one of the newly developed diagnostic tools to detect the pre-cancerous lesions m the bronchial tissue. Several studies have shown that AFB improved the rate of detection of cancer and dysplastic lesions of the airway, especially those in intraepithelial stage. However, there were high rates of false positive with AFB, and it is also important to develop non-biopsy methods because of lack of accurate information of variable course of preneoplastic lesions regarding progression. So, many other technologies were developed, such as narrow band imaging(NBI), endobronchoscopic ultrasound, optical coherence tomography, and confocal fluorescence microendoscopy. Among the new machines, NBI is a new optical technology that can clearly visualize the microvascular structure m the mucosal layer. NBI seems to increase specificity without compromising sensitivity. In the future such techniques would make it possible to precisely study in detail the natural history of the premalignant epithelium.